• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·COAG
Share

Hemab Therapeutics Holdings, Inc. Stocks

$ 49.65Last Updated 25.08.2026

Issuer Rating

3/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

$ 2.29B

$ 49.65
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Latest news

03.05.2026 21:00

S&P goes after SpaceX, Uzbekistan fund to offer discount: the main thing about the IPO by Ma. 3

01.05.2026 15:00

Hemab IPO: Novo-backed blood disorder biotech debuts on the Nasdaq

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

No company description

Company Valuation

Overvalued
2/7

From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks.

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of COAG is 41.2 and suggests 12.9% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to d

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

26.08.2026 14:50

Oninvest Index: Energy Small Caps Nearly Tripled the S&P 500. Who Are the Leaders?

26.08.2026 14:16

Dubai Airport reported a nearly one-third drop in passenger traffic due to the war

26.08.2026 13:23

Bets against Z.AI and MiniMax Have Reached a Peak: Why Doesn't the Market Believe in the "AI Dragons"?

26.08.2026 12:32

The ECB Is Prepared to Raise Rates for the Second Time This Year Due to the Impact of the War — Reuters

26.08.2026 11:42

Losses from short selling, a rap performance at an anniversary celebration, and criticism of SpaceX: what Einhorn wrote to investors

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026